cdc booster guidelines after having covid

However, some data indicate that the tablets can be split or crushed if necessary. What is the difference in the booster dose recommendation for children ages 6 months4 years who completed the Moderna vs Pfizer-BioNTech primary series? See Guidance for use of Janssen COVID-19 VaccineandUse of the Janssen (Johnson & Johnson) COVID-19 Vaccine for information on GBS and Janssen COVID-19 Vaccine. If you are age 18 or older, and got the Janssen COVID-19 vaccine, you can get either of the mRNA vaccine bivalent boosters at least two months after your shot. If my patient received a SARS-CoV-2 antibody product (anti-SARS-CoV-2 monoclonal antibodies or convalescent plasma) can they be vaccinated? COVID-19 vaccines can be administered any time after receipt of EVUSHELD. A bivalent mRNA vaccine is recommended for the booster dose. New COVID-19 booster shots specially formulated to fight multiple omicron variants are available now for children and adults ages 12 and over. Looking for U.S. government information and services. People who recently caught Covid can wait a few months to get a new omicron booster, White House Covid response coordinator Dr. Ashish Jha said on Tuesday. Day 1 is the first full day after your last exposure. The most common adverse effects of ritonavir-boosted nirmatrelvir are dysgeusia, diarrhea, hypertension, and myalgia. 1913 0 obj <> endobj Stader F, Khoo S, Stoeckle M, et al. 2022. Because of the potential for significant drug-drug interactions with concomitant medications, this regimen may not be the optimal choice for all patients. There are theoretical concerns that using a single antiviral agent in these patients may produce antiviral-resistant viruses. If a dose is administered earlier than the grace period, see Appendix D for guidance on corrective actions. But if youre currently dealing with an active infection, the Centers for Disease Control and Prevention recommends waiting at least until you no longer have symptoms and have met their criteria for ending isolation. Efficacy of antiviral agents against the SARS-CoV-2 Omicron subvariant BA.2. Do I need to wear a mask and avoid close contact with others if I am vaccinated? Ritonavir-boosted nirmatrelvir has significant drug-drug interactions, primarily due to the ritonavir component of the combination. Vangeel L, Chiu W, De Jonghe S, et al. Day 0 is the day of your last exposure to someone with COVID-19. Doses administered at any time after the recommended interval are valid. Most people with COVID-19 get better within a few days to a few weeks after infection, so at least four weeks after infection is the start of when post-COVID conditions could first be identified. My patient is asking for an antibody test to decide whether to get vaccinated (or revaccinated). 2023 CNBC LLC. Although Pfizer may provide partial protection against COVID-19 as soon as 12 days after the first dose, this protection is likely to be short lived. Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Patients who undergo HCT or CAR-T-cell therapy should be revaccinated for the monovalent primary series andbivalentmRNA booster dose received before or during treatment. Can COVID-19 vaccines be administered at the same time as an orthopoxvirus (monkeypox) vaccine? Lactation is not a contraindication for the use of ritonavir-boosted nirmatrelvir. The dosage is the same as the first booster dose One of the best ways scientists know how to measure that response is to look at how many antibodies youve produced. Some experts suggest delaying the repeat dose for 8 weeks after the invalid dose based on the potential for increased reactogenicity and the rare risk of myocarditis and pericarditis associated with Moderna, Novavax, and Pfizer-BioNTech vaccines, especially in males ages 1239 years. CDC strongly. Local indiana news 3 hours ago The CDC now recommends Pfizer boosters after 5 months, down from 6. The role of combination antiviral therapy or a longer treatment duration in treating patients who are severely immunocompromised is not yet known. Of course, deferring a booster isnt the right option for everyone. The dose should be reduced to nirmatrelvir 150 mg with ritonavir 100 mg twice daily in patients with moderate renal impairment (i.e., those with an estimated glomerular filtration rate [eGFR] of 30 to <60 mL/min). hb```, cbM Omicron BA.5 is the most contagious and immune-evasive form of the virus yet, Jha said at the time. People walk by a Covid-19 testing site at Times Square on May 12, 2022 in New York City. Both nirmatrelvir and ritonavir are substrates of CYP3A. Katzenmaier S, Markert C, Riedel KD, et al. Millions of people who have recently developed Covid-19 may have some new questions about their immunity. Takashita E, Kinoshita N, Yamayoshi S, et al. What do antibody tests tell us about immunity, and should these tests influence the decision to vaccinate or revaccinate? People who are vaccinated and recently caught Covid can wait three months to get their next shot, according to guidance from the CDC. The Centers for Disease Control and Prevention (CDC) is saying that before getting your Covid-19 vaccine or vaccine booster you should consider waiting for three months after you first. You will be subject to the destination website's privacy policy when you follow the link. Laboratory testing is not recommended for the purpose of vaccine decision-making. My patient who is moderately or severely immunocompromised underwent HCT or CAR-T cell therapy after receiving the primary series and 2 monovalent mRNA booster doses. HHS Secretary Xavier Becerra said on Tuesday that public health officials are particularly focused on making sure people ages 50 and older get boosted this month. Because ritonavir-boosted nirmatrelvir is the only highly effective oral antiviral for the treatment of COVID-19, drug-drug interactions that can be safely managed should not preclude the use of this medication. Fewer ritonavir-boosted nirmatrelvir recipients discontinued the study drug due to an adverse event than placebo recipients (2% vs. 4%). Yes. Longer treatment courses of ritonavir-boosted nirmatrelvir are not authorized by the current EUA, and there are insufficient data on the efficacy of administering a second course. Everyone who can get a vaccine, should get one, the CDC stressed. The effects also could lead to the development of new conditions, such as diabetes or a heart or nervous . Data is a real-time snapshot *Data is delayed at least 15 minutes. The CDC previously thought that infection provided about 90 days of protection, though it's become more common for people to get reinfected before then, Jha said. Do not revaccinate for the monovalent mRNA booster dose(s). But its still going to be lower than what we see with the vaccine.. The CDC advises that unvaccinated individuals who have contracted COVID-19 wait until symptoms have improved and at least ten days have passed since their positive test to get vaccinated.. Antibody testing is not currently recommended to assess the need for vaccination in an unvaccinated person or to assess immunity to SARS-CoV-2 following COVID-19 vaccination or after SARS-CoV-2 infection. Resulting in a lower-than-authorized dose: Repeat the dose immediately (no minimum interval) with the age-appropriate dose and formulation. Janssen COVID-19 Vaccine is not authorized for use as a second booster. For the Panels recommendations on preferred and alternative antiviral therapies for outpatients with COVID-19, see Therapeutic Management of Nonhospitalized Adults With COVID-19. Available at: Hammond J, Leister-Tebbe H, Gardner A, et al. Boosting with ritonavir, which is a strong CYP3A inhibitor and a P-glycoprotein inhibitor, is required to increase the exposure of nirmatrelvir to a concentration that is effective against SARS-CoV-2. Nirmatrelvir use and severe COVID-19 outcomes during the Omicron surge. Walensky made her recommendation just hours after CDC vaccine advisers voted unanimously to recommend booster doses of Pfizer/BioNTech's and Moderna's Covid-19 vaccines for all US adults. If you have a high risk of reinfection or serious illness whether because of your age, medical conditions, a weakened immune system or because you live or work in a setting that increases your likelihood of exposure then you may want to boost your immunity with an extra vaccine dose sooner rather than later, Dr. Ellebedy added. The CDC listed specific guidelines on who can avoid quarantining after a COVID-19 exposure, including: 1 . See the latest guidance from CDC for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Healthcare Systems. When ritonavir is used for 5 days, its induction properties are less likely to be clinically relevant than when the drug is used chronically (e.g., in people who take HIV protease inhibitors).30. 2022. Children in this age group who have not yet received the third Pfizer-BioNTech primary dose are recommended to receive a bivalent Pfizer-BioNTech dose as the third primary dose. So no, the vaccine can't make you test . In general, CDC recommends that people receive the age-appropriate vaccine dosage based on their age on the day of vaccination. People who recently had SARS-CoV-2 infection may consider delaying their primary series or booster COVID-19 vaccine dose by 3 months from symptom onset or positive test (if infection was asymptomatic). And most people who get vaccinated develop a strong and predictable antibody response. Anyone who was infected can experience post-COVID conditions. This will also allow for a more refined and durable response, he said. requirement to end isolation and may not occur until a few weeks (or even months) later. The EUA states that ritonavir-boosted nirmatrelvir is not recommended for patients with an eGFR of <30 mL/min until more data are available to establish appropriate dosing.3 Additional information is available in the initial FDA Center for Drug Evaluation and Research review for the EUA of ritonavir-boosted nirmatrelvir.15 Clinical experience on the use of ritonavir-boosted nirmatrelvir in patients who require hemodialysis is limited.24 Based on limited data, some groups have proposed dosing adjustments for ritonavir-boosted nirmatrelvir in patients with an eGFR of <30 mL/min and those who require hemodialysis.25-27 A clinical trial (ClinicalTrials.gov Identifier NCT05487040) that will evaluate the use of ritonavir-boosted nirmatrelvir in patients with COVID-19 and severe renal impairment is currently underway. GBS is a neurological disorder in which the bodys immune system damages nerve cells, causing muscle weakness and sometimes paralysis. People who were initially immunized with . ` 4 Arbel R, Wolff Sagy Y, Hoshen M, et al. However, if the second dose is administered after this interval, there is no need to restart the series. Can they get a bivalent booster dose? Vaccine effectiveness might also be increased with an interval longer than 3 or 4 weeks. CDC recommends COVID-19 vaccination for all people who are pregnant, breastfeeding, recently pregnant, trying to get pregnant now, or who might become pregnant in the future. Novavax monovalent COVID-19 Vaccine may be used as a booster dosein limited situationsfor people ages 18 years and older. What is the difference between booster doses and additional doses for immunocompromised individuals? People who don't meet the above criteria should still quarantine, the CDC says. An official website of the United States government. Phone the call centre if you need help booking an appointment. This can have a significant impact on quality of life and function. If a bivalent Moderna vaccine is administered for a primary dose: Repeat the dose immediately (no minimum interval) with a monovalent Moderna vaccine because administration of the bivalent Moderna vaccine will result in a lower-than-authorized primary series dosage. People who have stayed asymptomatic since the current COVID-19 exposure. Which COVID-19 vaccines are recommended for people with a history of Guillain-Barre syndrome (GBS)? The optimal timing will depend on your individual circumstances, including how severe your illness was, how long its been since your symptoms resolved and what your risk for re-exposure is. Official websites use .govA .gov website belongs to an official government organization in the United States. test, though this isnt a C.D.C. Can COVID-19 vaccines and other vaccines be administered at the same time? Ritonavir-boosted nirmatrelvir may be used in patients who are hospitalized for a diagnosis other than COVID-19, provided they have mild to moderate COVID-19, are at high risk of progressing to severe disease, and are within 5 days of symptom onset. Moderna or Pfizer-BioNTech) for each age group? Food and Drug Administration. My patient is moderately or severely immunocompromised and previously received EVUSHELD. Let your immune system rest after fighting off the coronavirus and before asking it to ramp up again with the vaccine. Its a surefire way to give further protection and make sure your immune system produces peak responses.. Not only will this help to produce a more robust antibody response, but by the time youre ready to be boosted, there might be a newer version of the vaccine available that will specifically work against Omicron. The immunity you gain after a Covid-19 infection might not be enough to fend off the virus again. Infants of mothers who were vaccinated and/or had COVID-19 or SARS-CoV-2 infection before or during pregnancy should be vaccinated according to the recommended schedule. In general, people whove been infected with the coronavirus tend to have lower levels of antibodies than those whove been vaccinated, said Aubree Gordon, an epidemiologist at the University of Michigan. In accordance with general best practicesfor immunizations, routine administration of all age-appropriate doses of vaccines simultaneously is recommended for children, adolescents, and adults for whom no specific contraindications exist at the time of the healthcare visit. Able to Mask Isolation Guidance; Yes Stay home and isolate for at least the first 5 days; you are probably most infectious during these 5 days Pfizer. Teens 12 to 17 may get the Pfizer booster. Ali Ellebedy, an immunologist at the Washington University School of Medicine in St. Louis, said that it might make sense to wait until youve fully recovered or can get a negative P.C.R. Centers for Disease Control and Prevention. Do not use the grace period to schedule doses. COVID-19 rapidly spreads from person-to-person contact and is also transmitted as it can stay alive and contagious for many days on surfaces. COVID-19 supplemental clinical guidance #4: nirmatrelvir/ritonavir (Paxlovid) use in patients with advanced chronic kidney disease and patients on dialysis with COVID-19. Studies have shown that waiting a few months after an infection to get boosted can result in a stronger immune response from the shot, according to the CDC. Wearing a mask for 10 days after exposure may reduce the risk of spreading COVID-19 to others. Ritonavir-boosted nirmatrelvir has significant drug-drug interactions, primarily due to the ritonavir component of the combination. There is no revaccination formonovalentmRNA booster dose(s) received before or during treatment. All information these cookies collect is aggregated and therefore anonymous. "COVID-19 vaccination decreases the risk of severe disease, hospitalization, and death from COVID-19. Now that there's a better understanding of the COVID-19 virus, the guidelines have changed. Viral and symptom rebound in untreated COVID-19 infection. Can vaccine from different manufacturers be used for the COVID-19 primary series? Ganatra S, Dani SS, Ahmad J, et al. For people with a history of GBS, as for the general population, mRNA (i.e., Moderna or Pfizer-BioNTech) and Novavax COVID-19 vaccines are recommended for the primary series, and an age-appropriate mRNA vaccine is recommended for the booster dose. Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants. If you choose to, get tested on Day 6. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Viral load rebound in placebo and nirmatrelvir-ritonavir treated COVID-19 patients is not associated with recurrence of severe disease or mutations. No pharmacokinetic or safety data are available for this patient population. 2022. What is the guidance for vaccinating infants of mothers who received COVID-19 vaccine and/or had COVID-19 or SARS-CoV-2 infection before or during pregnancy? If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Can the bivalent mRNA vaccines (i.e., Moderna and Pfizer-BioNTech) be used for the primary series? Booster doses All adults can get a booster if it's been 6 months or longer since their last COVID-19 booster or confirmed infection (whichever is most recent) for additional protection against severe illness from COVID. Californians continue to have access to vaccines, testing, and treatment to fight COVID-19. If you got the Pfizer-BioNTech vaccine, you can get a booster at least five months after completing that series. Photo: Getty Images. However, it may also increase concentrations of certain concomitant medications, thereby increasing the potential for serious and sometimes life-threatening drug toxicities. Early remdesivir to prevent progression to severe COVID-19 in outpatients. For information on using ritonavir-boosted nirmatrelvir in pediatric patients, see Special Considerations in Children, Therapeutic Management of Nonhospitalized Children With COVID-19, and Therapeutic Management of Hospitalized Children With COVID-19. The Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for ritonavir-boosted nirmatrelvir on December 22, 2021, for the treatment of COVID-19.3. For more information, see COVID-19 vaccines. Studies also suggest that the antibodies produced after vaccination tend to remain at protective levels for longer. For more information, see timing, spacing, age transitions, and interchangeability of COVID-19 vaccines. Vaccine guidance for most people The guidance outlined below is for people who are not moderately or severely immunocompromised. No, the monovalent mRNA vaccines (i.e., Moderna or Pfizer-BioNTech) are not authorized for use as a booster dose; they can only be used for the primary series. Adults (18 and older) can decide which booster to get, though Pfizer and Moderna boosters are preferred in most situations, per the CDC. `D[+F78Le Z;bWXj (q And theres so much Omicron around right now that if you havent gotten it already, then this is a chance to avoid getting it., https://www.nytimes.com/2022/02/03/well/live/booster-after-covid.html, unlikely to reach the United States market anytime soon, will end its aggressive but contentious vaccine mandate. A total of 2,246 patients enrolled in the trial. These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. People who received two doses and caught Covid had more than 50% protection against infection. Patients who were randomized within 3 days of symptom onset (n = 1,379) were included in the modified intention-to-treat (mITT) analysis. The booster provides real material help against preventing you from getting Omicron, Dr. Thomas said. In accordance with general best practices, preterm infants (infants born before 37 weeks gestation), regardless of birth weight, should receive COVID-19 vaccination at their chronological age and according to the same schedule and guidance as for full-term infants and children. What is the recommended bivalent booster vaccine (i.e. endstream endobj startxref Translators are available. A total of 2,224 patients who received at least 1 dose of either ritonavir-boosted nirmatrelvir or placebo were included in the EPIC-HR safety analysis set. According to the CDC, your protection against COVID-19 may decrease over time due to the virus' mutations. The patient is recommended to receive 1 bivalent mRNA booster dose at least 2 months after repeating the primary series. Studies have shown people who caught Covid after vaccination have substantial protection against the virus, though immunity wanes over time. Remdesivir, molnupiravir and nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern. Owen DR, Allerton CMN, Anderson AS, et al. Eligible patients were randomized within 5 days of symptom onset, were not vaccinated against COVID-19, and had at least 1 risk factor for progression to severe disease.4 Patients were excluded if they used medications that were either highly dependent upon CYP3A4 for clearance or strong inducers of CYP3A4. As a subscriber, you have 10 gift articles to give each month. We take your privacy seriously. Everyone ages 6 months and older is recommend to be vaccinated against COVID-19, including people who are moderately or severely immunocompromised and who previously received EVUSHELD for pre-exposure prophylaxis. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19. Those who have been within six feet of someone with COVID for a cumulative total of at least 15 minutes over a 24-hour period should stay home for 14 days after their last contact with that person and watch for symptoms. I was vaccinated in another country. Outside Canada and the USA: 1-604-681-4261. The mechanisms of action for both nirmatrelvir and ritonavir and the results of animal studies of ritonavir-boosted nirmatrelvir suggest that this regimen can be used safely in pregnant individuals. Should I wear a mask if I have a weak immune system? Post-COVID-19 condition refers to the longer-term effects some people experience after their COVID-19 infection. An alternative treatment for COVID-19 should be prescribed instead. Quarantine. For booster vaccination, Moderna and Pfizer-BioNTech are recommended. A woman receives a booster shot at a pop-up vaccination clinic in Las Vegas on Dec. 21. Inflammation and problems with the immune system can also happen. Before prescribing ritonavir-boosted nirmatrelvir, clinicians should carefully review the patients concomitant medications, including over-the-counter medications, herbal supplements, and recreational drugs, to evaluate potential drug-drug interactions. The decision about the second booster was especially intended for people ages 65 and up or ages 50 and up with chronic health conditions who had received their first booster dose at least four. Jha said everyone else age 12 or older should get a booster shot as soon as they can, particularly the elderly, people with serious medical conditions and those with weak immune systems. If your risk of reinfection is low for example if you work remotely, are generally healthy and can adhere to public health guidelines for masking and social distancing it might make sense to wait until your natural immunity is waning, which could occur up to three months after an infection, before getting boosted, he said. What should be done if the incorrect vaccine formulation is administered based on a patients age? Booster doses for children ages 6 months4 years who completed the Pfizer-BioNTech primary series are not currently authorized. For Healthcare Professionals: Ending Isolation and Precautions for People with COVID-19 When to Isolate According to the CDC, people who already had COVID-19 and do not get vaccinated after their recovery are more likely to get COVID-19 again than those who get vaccinated after their. He also said that it takes "three to four days" after getting the vaccine for your body to start creating antibodies and longer to develop full protection. While nearly 22 million adults 50 and older have received a second booster dose, most people 5 and . The third primary series dose can be either a monovalent Moderna vaccine or a bivalent Pfizer-BioNTech vaccine. (Meaning, if you had a mild infection, its been at least five days since your symptoms started, your symptoms are improving and youve been fever-free for at least 24 hours without the help of medications.). None of the currently authorized SARS-CoV-2 antibody testshave been validated to evaluate specific immunity or protection from SARS-CoV-2 infection. It's unclear how long people are protected after recovering from a BA.5 infection, Jha said in July. The CDC should recommend a 6-month interval between a previous booster or infection and the new updated vaccine for healthy adults for two primary reasons: updated immunologic studies and. For more information, see Coadministration of COVID-19 vaccines with other vaccines. Early in the pandemic, the CDC recommended waiting 90 days after a COVID-19 infection to get a vaccination. They help us to know which pages are the most and least popular and see how visitors move around the site. CDC COVID-19 Vaccination Interim Clinical Considerations FAQs for the Interim Clinical Considerations for COVID-19 Vaccination On This Page Vaccination Schedule and Use Vaccine Dosage and Formulation Booster Doses People who are Moderately or Severely Immunocompromised Vaccination and SARS-CoV-2 Laboratory Testing Heres what we know. Who can get a COVID-19 vaccine booster? Oral nirmatrelvir and ritonavir in non-hospitalized vaccinated patients with COVID-19. Rare cases of Bells palsy (acute peripheral facial nerve palsy) were reported following vaccination of participants in mRNA COVID-19 vaccine clinical trials, but FDA was not able to determine whether these cases were causally related to vaccination. For more information, see considerations for COVID-19 revaccination. An 8-week interval might be optimal for some people, especially males ages 1239 years because of the small risk of myocarditis and pericarditis associated with Moderna, Novavax, and Pfizer-BioNTech COVID-19 vaccines. Sign up for free newsletters and get more CNBC delivered to your inbox. Anaphylaxis and other hypersensitivity reactions have also been reported. The Moderna COVID-19 Vaccine, Bivalent is authorized for use as single booster dose in children 6 months through 5 years of age at least two months after completion of a primary series with the . If a child age 6 months4 years completed the 3-dose primary series with the monovalent Pfizer-BioNTech vaccine, can they also get a bivalent Pfizer-BioNTech vaccine dose? Yes. However, providers may administer 1 bivalent booster dose as a repeat dose based on clinical judgment and patient preference. For primary series vaccination, Moderna, Pfizer-BioNTech, and Novavax COVID-19 vaccines are recommended. Jha told reporters in July that breakthrough infections in people who are vaccinated have become more common since the omicron BA.5 variant became the dominant form of Covid over the summer. Doses administered up to 4 days before the minimum interval, known as the 4-day grace period, are considered valid. Should they be revaccinated? People who previously received SARS-CoV-2 antibody products (anti-SARS-CoV-2 monoclonal antibodies or convalescent plasma) as part of COVID-19 treatment, post-exposure prophylaxis, or pre-exposure prophylaxis can be vaccinated at any time; COVID-19 vaccination does not need to be delayed following receipt of monoclonal antibodies or convalescent plasma. Food and Drug Administration. For more information, see Interchangeability of COVID-19 vaccine products. Among these patients, dysgeusia and diarrhea occurred more frequently in ritonavir-boosted nirmatrelvir recipients than in placebo recipients (6% vs. 0.3% and 3% vs. 2%, respectively). This means people who were previously infected and get an omicron booster might have longer protection against Covid, according to a presentation from last week's CDC committee meeting on the shots. hbbd```b``^"HZ&5"R`2D*z} 8w&d0LG2012se)"3 Forty-seven percent of the patients tested negative for SARS-CoV-2 antibodies, and 66% started study treatment within 3 days of symptom onset. All Rights Reserved. Ages 6 years and older: 1 bivalent mRNA booster dose (Moderna or Pfizer-BioNTech) regardless of which vaccine they received for their primary series. And the guidance on when to schedule a booster appointment after recovering from Covid-19 is less than clear. Less than 60% of all Utahns are considered fully vaccinated, meaning it's been two weeks or more since completing their initial series of shots. Greasley SE, Noell S, Plotnikova O, et al. Learn more Check the Governor's updates Current safety measures Vaccines Vaccination records Masks Travel Get tested Long COVID Treatments Safety in the workplace Tracking COVID-19 in CA Can a monovalent mRNA vaccine (i.e., Moderna or Pfizer-BioNTech) be used for the booster dose? }*1%5O* g|1mK**e8=*yH%&\ J&{UnI1. 2022. Rebound of SARS-CoV-2 infection after nirmatrelvir-ritonavir treatment. There are no data on combining ritonavir-boosted nirmatrelvir with other antiviral therapies to treat nonhospitalized patients with COVID-19.

Fluzina Oxigenador Cerebral, Beach Cottage Oak Vinyl Plank, 1/4 Cup Dry Black Beans Nutrition, Mmo Champion Guild Recruitment, James Cutler Architect Net Worth, Articles C